-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q2 2025.
- InMed Pharmaceuticals Inc. Depreciation for the quarter ending June 30, 2025 was $12.2K, a 124% increase year-over-year.
- InMed Pharmaceuticals Inc. Depreciation for the twelve months ending June 30, 2025 was $50.2K, a 5.16% increase year-over-year.
- InMed Pharmaceuticals Inc. annual Depreciation for 2025 was $50.2K, a 5.16% increase from 2024.
- InMed Pharmaceuticals Inc. annual Depreciation for 2024 was $47.7K, a 20.5% increase from 2023.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)